Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice

Jorgensen, 1999, Epidemiology of stroke-related disability, Clin. Geriatr. Med., 15, 785, 10.1016/S0749-0690(18)30031-4 Frizzell, 2005, Acute stroke: pathophysiology, diagnosis, and treatment, AACN Clin. Issues, 16, 421, 10.1097/00044067-200510000-00002 Kita, 1999, Stroke incidence and case fatality in Shiga, Japan 1989-1993, Int. J. Epidemiol., 28, 1059, 10.1093/ije/28.6.1059 Warlow, 1998, Epidemiology of stroke, Lancet, 352, SIII 1, 10.1016/S0140-6736(98)90086-1 Hankey, 1999, Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations, Lancet, 354, 1457, 10.1016/S0140-6736(99)04407-4 Kwiatkowski, 1999, Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group, N. Engl. J. Med., 340, 1781, 10.1056/NEJM199906103402302 Felberg, 2000, Neuroprotection and the ischemic cascade, CNS Spectrums, 5, 52, 10.1017/S1092852900012967 Mogi, 2006, New paradigm for brain protection after stroke, Hypertension, 47, 642, 10.1161/01.HYP.0000208621.87845.67 Schaller, 2004, Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy, J. Cereb. Blood Flow Metab., 24, 351, 10.1097/00004647-200404000-00001 Danton, 2003, Inflammatory mechanisms after ischemia and stroke, J. Neuropathol. Exp. Neurol., 62, 127, 10.1093/jnen/62.2.127 Jean, 1998, Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon, Neurosurgery, 43, 1382 Huang, 2006, Inflammation in stroke and focal cerebral ischemia, Surg. Neurol., 66, 232, 10.1016/j.surneu.2005.12.028 Khan, 2004, Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke, J. Neurosci. Res., 76, 519, 10.1002/jnr.20087 Kanemoto, 2002, Effects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model, Neurosurgery, 51, 1034 Miyake, 2004, Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2, Trends Microbiol., 12, 186, 10.1016/j.tim.2004.02.009 Miller, 2005, LPS, TLR4 and infectious disease diversity, Nat. Rev. Microbiol., 3, 36, 10.1038/nrmicro1068 Michelsen, 2004, TLR4 signaling: an emerging bridge from innate immunity to atherogenesis, J. Immunol., 173, 5901, 10.4049/jimmunol.173.10.5901 Oyama, 2004, Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice, Circulation, 109, 784, 10.1161/01.CIR.0000112575.66565.84 Tsung, 2005, Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells, J. Immunol., 175, 7661, 10.4049/jimmunol.175.11.7661 Zhai, 2004, Cutting Edge:TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN redulatory factor 3-dependent MyD88-independent pathway, J. Immunol., 173, 7115, 10.4049/jimmunol.173.12.7115 Poltorak, 1998, Defective LPS siganaling in C3H/Hej and C57BL/10ScCr mice: mutation in TLR4 gene, Science, 282, 2085, 10.1126/science.282.5396.2085 Longa, 1989, Reversible middle cerebral artery occlusion without craniectomy in rats, Stroke, 20, 84, 10.1161/01.STR.20.1.84 Majid, 2000, Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains, Stroke, 31, 2707, 10.1161/01.STR.31.11.2707 Andrem, 2000, Toll-like receptors in the induction of the innate immune response, Nature, 406, 782, 10.1038/35021228 Lehnardt, 2003, Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway, Proc. Natl. Acad. Sci. USA, 100, 8514, 10.1073/pnas.1432609100 Tsan, 2004, Endogenous ligands of Toll-like receptors, J. Leukoc. Biol., 76, 514, 10.1189/jlb.0304127 Okashi, 2000, Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex, J. Immunol., 164, 558, 10.4049/jimmunol.164.2.558 Vabulas, 2002, The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway, J. Biol. Chem., 277, 20847, 10.1074/jbc.M200425200 Johnson, 2002, Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4, J. Immunol., 168, 5233, 10.4049/jimmunol.168.10.5233 Vink, 2002, In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions, Circulation, 106, 1985, 10.1161/01.CIR.0000032146.75113.EE Offner, 2006, Experimental stroke induces massive, rapid activation of the peripheral immune system, J. Cereb. Blood Flow Metab., 26, 654, 10.1038/sj.jcbfm.9600217 Chakravarty, 2005, Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines, J. Neurosci., 25, 1788, 10.1523/JNEUROSCI.4268-04.2005